SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Analyst Earnings Estimates
FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 821.1M 26.58% | 898.602M 9.44% | 957.091M 6.51% | 1.033B 7.93% | 1.14B 10.36% | 1.264B 10.88% | 1.401B 10.84% | 1.532B 9.35% | 2.014B 31.46% | 2.074B 2.98% | |
| EBITDA YoY % growth | 223.5M 47.72% | 217.822M -2.54% | 255.565M 17.33% | 266.95M 4.45% | 316.02M 18.38% | 377.38M 19.42% | 423.24M 12.15% | 464.39M 9.72% | 562.43M 21.11% | 604.82M 7.54% | |
| EBIT YoY % growth | 168.1M 46.30% | 171.174M 1.83% | 190.587M 11.34% | 204.27M 7.18% | 245.5M 20.18% | 285.04M 16.11% | 315.59M 10.72% | 343.65M 8.89% | N/A | N/A | |
| Operating Margin | 20.47% | 19.05% | 19.91% | 19.77% | 21.54% | 22.55% | 22.53% | 22.43% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | 0.99 4.50% | 1.04 4.94% | 1.25 20.61% | 1.44 15.23% | 1.65 14.60% | 1.82 9.78% | N/A | N/A |
All data in EUR
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.30 -2.54% | 0.26 19.93% |
| Revenue Q2Q % growth | 268.59M 5.92% | 265.96M 12.20% |
| EBITDA Q2Q % growth | 77.142M -23.94% | 70.934M -35.15% |
| EBIT Q2Q % growth | 57.584M 5.78% | 51.438M 15.82% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.26 52.94% | 0.25 | 0.01 | 5.48% |
| Q1 2025 Q2Q % growth | 0.19 -34.48% | 0.22 | -0.03 | -14.42% |
| Q4 2024 Q2Q % growth | 0.22 -4.35% | 0.25 | -0.03 | -10.99% |
| Q3 2024 Q2Q % growth | 0.31 | 0.21 | 0.10 | 50.83% |
| Q2 2024 Q2Q % growth | 0.17 | 0.21 | -0.04 | -20.63% |
| Q1 2024 Q2Q % growth | 0.29 | 0.28 | 0.01 | 3.11% |
| Q4 2023 Q2Q % growth | 0.23 | 0.16 | 0.07 | 40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 252.326M 7.95% | 247.99M | 4.336M | 1.75% |
| Q1 2025 Q2Q % growth | 229.841M -1.04% | 242.74M | -12.899M | -5.31% |
| Q4 2024 Q2Q % growth | 237.051M 3.73% | 244.39M | -7.339M | -3.00% |
| Q3 2024 Q2Q % growth | 253.587M -62.16% | 228.25M | 25.337M | 11.10% |
| Q2 2024 Q2Q % growth | 233.749M | 238.89M | -5.141M | -2.15% |
| Q1 2024 Q2Q % growth | 232.251M | 212M | 20.251M | 9.55% |
| Q4 2023 Q2Q % growth | 228.516M 12.57% | 233.12M | -4.604M | -1.97% |
| Q3 2023 Q2Q % growth | 670.086M 8.41% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.21% | -0.16% | 0% | 0% |
| Revenue | -1.2% | -3.51% | -0.58% | -0.58% |